CGIP20087 / A021806 / Richard DunneResearch Question:
How does perioperative chemotherapy (given before and after surgery) compare to adjuvant
chemotherapy (given after surgery) for the treatment of pancreatic cancer that can
be removed by surgery (removable/resectable)?
Basic Study Information
Purpose:Location: University of Rochester Medical Center
This phase III trial compares perioperative chemotherapy (given before and after surgery)
versus adjuvant chemotherapy (given after surgery) for the treatment of pancreatic
cancer that can be removed by surgery (removable/resectable). Chemotherapy drugs,
such as fluorouracil, irinotecan, leucovorin, and oxaliplatin, work in different ways
to stop the growth of tumor cells, either by killing the cells, by stopping them from
dividing, or by stopping them from spreading. Giving chemotherapy before and after
surgery (perioperatively) may work better in treating patients with pancreatic cancer
compared to giving chemotherapy after surgery (adjuvantly).
Study Reference #: CGIP20087
Lead Researcher (Principal Investigator)
Study Contact Information
Study Contact: Clinical Trials Office
Study Location: Wilmot Cancer Institute, University of Rochester Medical Center
Study Email: WCICTOResearch@urmc.rochester.edu
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search